Photo of Jonathan Siverskog

Jonathan Siverskog


When is a new drug too expensive? The topic of my research is the opportunity cost of health spending. How much health could have been gained, had we instead devoted the resources to, e.g., reducing waiting lists or providing more hospital beds?

Opportunity cost in economic evaluation

The resources available for the public provision of health care are not unlimited. Cost-effectiveness evidence on new healthcare interventions can help us prioritise in order to use scarce resources wisely, but to interpret cost-effectiveness evidence, it may appear as if we must make trade-offs between life and money.

This is not so. If we are able to quantify the health improvements that resources would or could have generated in alternative use, a decision about providing or denying treatment can instead be framed as a trade-off between health gained and health forgone.

In my research, I seek to provide a more robust basis for this way of reporting and interpreting cost-effectiveness evidence.


  • B.Sc. in Political Sciences, 2013
  • M.Sc. in Economics, 2015
  • Ph.D. in Medical Sciences, 2022


I teach econometrics at the Master Programme in Economics.



Jonathan Siverskog (2023) Making the rules make sense: valuation of constrained resources European Journal of Health Economics, Vol. 24, Article 481 Continue to DOI
Kasper Johannesen, Jonathan Siverskog, Martin Henriksson, Magnus Janzon, Bertil Lindahl, Erik Groenqvist (2023) Implementation of Ticagrelor Reduced Mortality in Routine Clinical Care: Evidence From a Natural Experiment Including 109 995 Patients With Myocardial Infarction in Sweden Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 12 Continue to DOI


Jonathan Siverskog, Martin Henriksson (2022) Ekonomiska utvärderingar och avvägningen mellan effektivitet och rättvisa Prioriteringscentrum - 20 år i rättvisans tjänst, p. 175-182
Jonathan Siverskog, Martin Henriksson (2022) The health cost of reducing hospital bed capacity Social Science and Medicine, Vol. 313, Article 115399 Continue to DOI
Jonathan Siverskog (2022) Opportunity cost in healthcare priority setting


Research affiliation